Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
13.20 PLN
57.83 B PLN
166.31 B PLN
3.16 B
About NOVO NORDISK B A/S
Sector
Industry
CEO
Lars Fruergaard Jørgensen
Website
Headquarters
Bagsværd
Founded
1931
ISIN
DK0062498333
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Novo 1h longShould get up and at least break the neckline from the bigger SHS/IHS.
Stop below zone or lower trendline.
NVO buyThis downturn has been influenced by several factors:
Leadership Changes: CEO Lars Fruergaard Jørgensen is stepping down after eight years, following a sharp decline in the company's stock price.
STAT
+8
MarketWatch
+8
WSJ
+8
Increased Competition: Eli Lilly's weight-loss drugs, Mounjaro and Zepb
NOV - CONTINUATION OF A DOWNTREND OR START OF A NEWGood Morning,
Hope all is well. NVO has been in a down trend since Feb 26 2025, like most stocks. NVO tried to move past the 70$ price point however it was rejected and is now seeking lower support. Currently for trend there is an ascending channel. A break above the mid-line is bullish, a failure
NVO entering a great buying zoneNOVO has entered into the golden retracement for and good buying zone.
Looking to buy between 62.50 and 60.
Sell targets $90, 110 and 135.
Novo Nordisk Stock Chart Fibonacci Analysis 050925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 411/61.80%
Chart time frame: D
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
NVO - looking for move upMy MVP system
M: rsi bottoming, rounded w a higher low
V: solid increase in vol
P: steep downward channel; could have nice pop to the upside; I would like the price better if it were forming a base instead of a steep down path, though price did hit a prior support/resistance zone
*Im wondering if
NVO-Buy here, thank me a year laterNVO at golden buy zone
Currently Bouncing off 100 Monthly SMA roughly 55% discount from its ATH
Now is a great time for buy long term hold IMO
Novo Nordisk (NVO) – Oversold Reversal + Earnings CatalystNovo Nordisk (NVO) has declined 61.13% from its all-time high of $148 (June 2024), finding support at $57.55. Over the past two weeks, the stock has rebounded over 15%, currently trading around $66.30, with strong reversal signals just ahead of earnings.
This setup presents a compelling opportunity
NVO Thesis earningsEarnings from LLY proved to be good on their fat drugs with concerns on tariffs for other items in their portfolio. Knowing that NVO is primary obesity with deals on the table from CVS and HIMS it is in the line of thinking that earnings will be in line with positive guidance in anticipation of mar
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Curated watchlists where NVO is featured.
Related stocks
Frequently Asked Questions
The current price of NVO is 254.00 PLN — it hasn't changed in the past 24 hours. Watch NVONORDSK stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange NVONORDSK stocks are traded under the ticker NVO.
NVO stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in NVONORDSK price.
We've gathered analysts' opinions on NVONORDSK future price: according to them, NVO price has a max estimate of 514.27 PLN and a min estimate of 199.99 PLN. Watch NVO chart and read a more detailed NVONORDSK stock forecast: see what analysts think of NVONORDSK and suggest that you do with its stocks.
NVO stock is 0.00% volatile and has beta coefficient of 1.41. Track NVONORDSK stock price on the chart and check out the list of the most volatile stocks — is NVONORDSK there?
Today NVONORDSK has the market capitalization of 1.14 T, it has increased by 1.17% over the last week.
Yes, you can track NVONORDSK financials in yearly and quarterly reports right on TradingView.
NVONORDSK is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
NVO earnings for the last quarter are 3.67 PLN per share, whereas the estimation was 3.43 PLN resulting in a 6.95% surprise. The estimated earnings for the next quarter are 3.39 PLN per share. See more details about NVONORDSK earnings.
NVONORDSK revenue for the last quarter amounts to 43.84 B PLN, despite the estimated figure of 43.76 B PLN. In the next quarter, revenue is expected to reach 44.11 B PLN.
NVO net income for the last quarter is 16.30 B PLN, while the quarter before that showed 16.17 B PLN of net income which accounts for 0.83% change. Track more NVONORDSK financial stats to get the full picture.
NVONORDSK dividend yield was 1.83% in 2024, and payout ratio reached 50.28%. The year before the numbers were 1.35% and 50.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 29, 2025, the company has 76.3 K employees. See our rating of the largest employees — is NVONORDSK on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NVONORDSK EBITDA is 88.05 B PLN, and current EBITDA margin is 50.95%. See more stats in NVONORDSK financial statements.
Like other stocks, NVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NVONORDSK stock right from TradingView charts — choose your broker and connect to your account.